From the Center
AllSides Media Bias Rating: Center
Food and Drug Administration (FDA) Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, despite a steady pressure campaign from abortion opponents.
Speaking at the Semafor World Economy Summit on Thursday, Makary said he would reconsider if there is new data that would suggest a safety issue.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.